Do reminder messages impact HPV vaccination rates?
Existing research suggests that reminder messages, or state immunization information systems autodialer centralized reminder and recall (C-R/R) messages, are likely to result in higher child vaccination rates.
Existing research suggests that reminder messages, or state immunization information systems autodialer centralized reminder and recall (C-R/R) messages, are likely to result in higher child vaccination rates. However, little data exist on the potential connection between reminders and human papilloma virus (HPV) vaccination rates.
This research is highly valuable as HPV remains the most common sexually transmitted infection the United States, according to the Centers for Disease Control and Prevention. Nearly 80 percent of sexually active people are likely to contract HPV in their lifetime with 14 million new infections occurring each year, says the American Sexual Health Association.
Researchers conducted a new study to address the knowledge gap and explore the possible impacts. The study’s findings, published in Pediatrics, suggest that reminder messages may not be as successful for improving HPV vaccination rates as they are others.
Read the full article for more information.
NIH study finds long-acting ART safe for HIV suppression in adolescents
March 7th 2024Research presented at the 2024 Conference on Retroviruses and Opportunistic Infections reveals that long-acting injectable antiretroviral therapy provides improved HIV suppression with minimal adverse effects, offering a promising alternative for adolescents and individuals struggling with daily oral regimens.
Read More
HIV remission among children reported over 1 year after treatment interruption
March 7th 2024Research presented at the 2024 Conference on Retroviruses and Opportunistic Infections reveals that 4 children, treated with antiretroviral therapy within 48 hours of birth, have achieved over a year of HIV remission.
Read More
Evaluating GeneXpert point-of-care testing for STIs
March 6th 2024A recent study assessed the effectiveness of GeneXpert point-of-care testing in detecting chlamydia, gonorrhoea, and trichomonas, revealing promising results but highlighting concerns over sensitivity rates, particularly for trichomonas.
Read More
